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OBJECTIVE—Adipose tissue may contain few large adipocytes
(hypertrophy) or many small adipocytes (hyperplasia). We inves-
tigated factors of putative importance for adipose tissue
morphology.
RESEARCH DESIGN AND METHODS—Subcutaneous adipo-
cyte size and total fat mass were compared in 764 subjects with
BMI 18–60 kg/m
2. A morphology value was deﬁned as the
difference between the measured adipocyte volume and the
expected volume given by a curved-line ﬁt for a given body fat
mass and was related to insulin values. In 35 subjects, in vivo
adipocyte turnover was measured by exploiting incorporation of
atmospheric
14C into DNA.
RESULTS—Occurrence of hyperplasia (negative morphology
value) or hypertrophy (positive morphology value) was indepen-
dent of sex and body weight but correlated with fasting plasma
insulin levels and insulin sensitivity, independent of adipocyte
volume (-coefﬁcient  0.3, P  0.0001). Total adipocyte number
and morphology were negatively related (r  0.66); i.e., the
total adipocyte number was greatest in pronounced hyperplasia
and smallest in pronounced hypertrophy. The absolute number
of new adipocytes generated each year was 70% lower (P 
0.001) in hypertrophy than in hyperplasia, and individual values
for adipocyte generation and morphology were strongly related
(r  0.7, P  0.001). The relative death rate (10% per year) or
mean age of adipocytes (10 years) was not correlated with
morphology.
CONCLUSIONS—Adipose tissue morphology correlates with
insulin measures and is linked to the total adipocyte number
independently of sex and body fat level. Low generation rates of
adipocytes associate with adipose tissue hypertrophy, whereas
high generation rates associate with adipose hyperplasia.
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dipose tissue expands by increasing the volume
of preexisting adipocytes (adipose hypertro-
phy), by generating new small adipocytes (hy-
perplasia), or by both. Although the amount
and distribution of adipose tissue associate independently
with insulin resistance, type 2 diabetes, and other meta-
bolic disorders (1), the size of adipocytes within the
adipose tissue is also important (2). Increased adipocyte
size correlates with serum insulin concentrations, insulin
resistance, and increased risk of developing type 2 diabe-
tes (3–10). Obese subjects with few large adipocytes are
more glucose intolerant and hyperinsulinemic than those
having the same degree of obesity and many small fat cells
(5,7,9–14). Furthermore, adipocyte hypertrophy may im-
pair adipose tissue function by inducing local inﬂamma-
tion, mechanical stress, and altered metabolism (15–17).
There is, however, a large interindividual variation in adipo-
cyte size among lean and obese individuals (10,18,19). Lean
individuals can have larger adipocytes than obese individ-
uals and the other way around. Hitherto there is no
straightforward method to assess adipose morphology. It
is not valid to merely adjust fat cell size for BMI by linear
regression because the relationship between BMI or fat
mass and adipocyte size is curve-linear (10,18,19).
The mechanisms responsible for the development of
different forms of adipose morphology are unknown;
however, adipocyte turnover may be involved. The turn-
over rate of adipocytes is high at all adult ages and body
fat levels (18). Approximately one-tenth of the total fat cell
pool is renewed every year by ongoing adipogenesis and
adipocyte death.
We presently investigated whether adipocyte turnover
was involved in the different morphologies of subcutane-
ous adipose tissue (the body’s dominant fat depot). A
method to quantitatively assess adipose morphology was
developed. Based on the relationship between adipocyte
size and total body fat, the subjects were categorized as
having different degrees of either adipose hypertrophy or
hyperplasia. Thereafter, we set the different forms of
adipose morphology in relation to adipocyte turnover in
vivo using previously generated data on the incorporation
of atmospheric
14C into adipocyte DNA (18). Finally, we
correlated adipose morphology with fasting plasma insulin
and insulin sensitivity in vivo.
RESEARCH DESIGN AND METHODS
In a methodological study, 207 men and 557 women (aged 18–77 years) were
recruited. Seventy-four men and 172 women were lean (BMI 25 kg/m
2), and
86 men and 318 women were obese (BMI 30 kg/m
2). Total body fat was
determined by a formula based on age, sex, and BMI (20). In 555 of the
subjects, body fat was also determined by directly using bioimpedance as
previously described (18). Fasting plasma levels of glucose and insulin were
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diabetes.diabetesjournals.org DIABETES, VOL. 59, JANUARY 2010 105determined in 716 of the subjects to assess in vivo sensitivity by the
homeostasis model assessment (HOMA) index (21). The relation between
adipose tissue morphology and adipocyte turnover was determined in 35
subjects who were previously investigated (18) and who were not part of the
methodological study. The studies were approved by the regional ethics
committee and explained in detail to each subject. Written informed consent
was obtained.
Adipose tissue studies. In the methodological study, an abdominal subcu-
taneous fat specimen was obtained by needle biopsy as previously described
(22). Adipocytes were collagenase isolated, and mean volume and total
number of adipocytes in the body were determined as previously described
(18). The total adipocyte number in the body was obtained by dividing total
weight of body fat by mean adipocyte weight (23). A curve ﬁt of the
relationship between adipocyte volume and body fat mass was performed as
previously described (18). The difference between observed and expected
adipocyte volume (as obtained from the ﬁtted curve) at the corresponding
level of total body fat mass was calculated for each subject. The subjects then
were classiﬁed as having either hyperplasia (negative deviation) or hypertro-
phy (positive deviation) relative to the estimated average for their value of
body fat. The renewal of adipocytes in vivo was estimated using our recently
developed method to measure
14C in DNA (18,24) and set it in relation to the
atmospheric radioactivity. Relative adipocyte turnover rate and adipocyte age
were estimated using a mathematical model for cell birth and death (18). The
total number of adipocytes replaced each year was calculated based on the
relative turnover, total cell number, and age of each subject (18).
Statistical methods. Values are means  SD or box plots. They were
compared by ANCOVA, unpaired t test, single or multiple regression, and 
2.
Values for adipocyte generation rate (in 10
10 cellsper year) and HOMA index
were log transformed to obtain a normal distribution. A likelihood ratio test
and Akaike information test were used as previously described (18). Power
calculations on means and SD for the entire group of subjects with
14C data
showed that for age, relative death rate, and generation rate of adipocytes, we
could detect between-group difference of 20% with 80% power at P 0.05.
Additional information. Further details about the research design and
methods can be found in the online appendix, available at http://diabetes.
diabetesjournals.org/cgi/content/full/db09-0942/DC1.
RESULTS
The relationship between adipocyte volume and fat mass
is shown in Fig. 1A. All subjects with a total body fat mass
13 kg were lean, and those with a fat mass 36 kg were
obese. The relationship between fat mass and adipocyte
volume ﬁts a curve-linear model, which postulates that
adipose tissue development is due to a combination of an
increase in volume of preexisting adipocytes and the
generation of new adipocytes (P  0.001 by likelihood
ratio test and Akaike information criterion as compared
with a linear model). The positions of the curved-lines for
women and men were slightly different (P  0.05 by
unpaired t test). Therefore, sex-speciﬁc relationships were
used to classify subjects according to morphology. When
bioimpedance was used on a subgroup, the relationship
between body fat and adipocytes size did not differ signif-
icantly from the formula-based calculation of fat mass
(Fig. 1B), indicating that the formula-derived fat mass is
valid for determining adipose morphology. A morphology
value was deﬁned as the difference between measured and
expected adipocyte volume given by the curved-line ﬁt for
a given body fat mass. A positive morphology value
indicates an adipocyte volume larger than expected, while
a negative morphology value indicates an adipocyte vol-
ume smaller than expected. In the remaining analyses,
subjects with positive morphology values were classiﬁed
as hypertrophic and those with negative morphology val-
ues were classiﬁed as hyperplastic. Large absolute mor-
phology values indicate pronounced hypertrophy or
hyperplasia. The morphology values were normally dis-
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FIG. 1. Adipose morphology. A: Curve-linear relationship between fat cell volume and fat mass in all 764 subjects. B: Comparison of curves
obtained from fat mass measured with a formula and by bioimpedance in a subset of 555 subjects. C: Distribution of adipose tissue morphology
values. D: Frequency of different forms of morphology in male (n  207), female (n  557), nonobese (n  300), and obese (n  404) subjects.
The morphology value is deﬁned in the RESULTS section.
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deviate from the mean (P  0.82). This was also true when
data were subdivided according to sex or obesity status.
Each form of morphology was almost equally common
(394 negative and 370 positive values). Sex and obesity
had no inﬂuence on the frequency of hypertrophy or
hyperplasia (Fig. 1D).
The morphology value (r  0.61) (Fig. 2A) but not the
unadjusted measured adipocyte volume (r  0.11) (Fig.
2B) correlated (P  0.0001) with total adipocyte number in
a quantitative fashion, i.e., the higher the degree of hyper-
plasia, the greater the number of adipocytes and the other
way around for hyperthrophy.
Adipocyte turnover in vivo is shown in Fig. 3. The
number of adipocytes added per year was 70% reduced
in the 12 hypertrophy subjects compared with the 23
hyperplasia subjects (Fig. 3A)( P  0.027 by unpaired t test
and P  0.02 by ANCOVA with BMI as co-variate using 10
log-transformed data). The average number of adipocytes
generated per year (10
10 cells per year) was 1.2 in hyper-
plasia and 0.4 in hyperthrophy. The individual morphology
values were inversely related to the number of adipocytes
generated per year (r  0.70, P  0.001 by linear
regression of 10 log-transformed adipocyte production
data in Fig. 3B and -coefﬁcient  0.65 and P  0.001
after correction for inﬂuence of BMI by multiple regres-
sion). Age (10 years) and relative death rate (10% per
year) of adipocytes were not different between hyperpla-
sia and hypertrophy (Fig. 3C and D).
Finally, we investigated the clinical impact of adipose
morphology (Table 1). In all subjects, in men and women
separately, or in those who were healthy and free of
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FIG. 2. Relationship between total fat cell number and adipose morphology values (A) or fat cell size (B) in all 764 subjects. The morphology value
is deﬁned in the RESULTS section.
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FIG. 3. Role of adipocyte turnover for adipose tissue morphology in hypertrophy (n  12) or hyperplasia (n  23) subjects. Production rate of
new fat cells is shown by groups (A) and in individual subjects (B). The statistical calculation used log-transformed values. Age (C) and death
rates (D) of fat cells. The morphology value is deﬁned in the RESULTS section.
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(HOMA index) correlated (P 0.001) with the morphology
value independently of unadjusted adipocyte volume.
Women with hypertrophy had a more unfavorable meta-
bolic proﬁle and body shape than women with hyperplasia
(supplementary Table 1).
DISCUSSION
Using a biologically relevant relationship between the fat
mass and adipocyte volume, we developed a novel and
apparently valid method to assess quantitatively subcuta-
neous abdominal adipose tissue morphology. It would also
be interesting to study visceral adipose tissue, which is
more strongly related to type 2 diabetes and metabolic
abnormalities; however, this cannot be investigated in a
clinical setting. Whether the inclusion of several rather
than only one subcutaneous site would result in an im-
provement in the accuracy to determine the morphology is
not known at present. However, adipocyte sizes in other
subcutaneous depots are the strongest determinants of
adipocyte size in any given subcutaneous depot (19).
Furthermore, it is not possible for ethical reasons to
perform multiple biopsies (abdomen, buttocks, legs, arms,
and neck) from lean subjects who were included in this
study. There is a large variation in adipocyte size within
the same subject and fat depot (25). Detailed classiﬁcation
requires the separation of isolated adipocytes according to
size (15,17), which is not feasible using small amounts of
adipose tissue.
The occurrence of adipose hypertrophy or hyperplasia
was not inﬂuenced by sex or body weight (Fig. 1C). This
suggests that hyperplasia and hypertrophy are equally
common among men and women and evenly distributed
among lean, overweight, or obese subjects in a general
population. Furthermore, subcutaneous adipose morphol-
ogy is tightly correlated with the total adipocyte number in
the body over a large BMI range (18–60 kg/m
2). This may
imply that common factors regulate adipose morphology
and adipocyte number.
Adipose morphology seems to be related to the genera-
tion of new adipocytes. Subjects with hypertrophy gener-
ated 70% less adipocytes per year than those with
hyperplasia, and there was an inverse quantitative rela-
tionship between the residual value for adipocyte volume
and adipocyte production rate (i.e., the higher the degree
of hypertrophy, the lower the rate of adipocyte formation)
(Fig. 3A and B). These ﬁndings suggest that in hypertro-
phy, the body produces few adipocytes over time, requir-
ing existing adipocytes to accumulate more lipids in
comparison with the hyperplastic state. Age and relative
death rate of adipocytes were not inﬂuenced by morphol-
ogy (Fig. 3C and D), indicating that the overall percentage
of adipocytes replaced each year is similar in hypertrophic
and hyperplastic states. Obese individuals have more
adipocytes added per year than lean individuals (18), but
the relationship between morphology and adipocyte pro-
duction is independent of BMI. Thus, de novo adipogene-
sis is important for both obesity and morphology of human
adipose tissue.
Obviously, the volume of adipocytes in adipose tissue is
not the same as adipose tissue morphology. Subjects with
hypertrophy or hyperplasia can have either small or large
adipocytes dependent on their body fat content (Fig. 1A).
Thus, absolute adipocyte size is strongly dependent on the
degree of overweight/obesity, whereas the difference be-
tween observed and expected adipocyte volume, measur-
ing morphology, is adjusted for the fat mass. Furthermore,
the nonadjusted adipocyte volume, unlike the morphology
value, was not related to adipocyte number (Fig. 2B).
We also found that adipose morphology was an inde-
pendent regressor for circulating insulin and insulin sen-
sitivity (Table 1) and that women with hypertrophy had a
more adverse metabolic proﬁle and body shape than
women with hyperplasia, although BMI was similar in both
groups (supplementary Table 1). The true pathophysiolog-
ical role of adipose morphology must, though, be estab-
lished by studies of populations selected for risk factor
investigation and investigations of visceral adipose tissue.
We investigated a Swedish population. It is not known
how the results model other populations. In summary,
subcutaneous adipose hypertrophy and hyperplasia occur
independently of sex and body fat content and are strongly
related to the total adipocyte number in adults. A low
generation rate of new adipocytes associates with adipose
hypertrophy, which is linked to low insulin sensitivity and
high circulating insulin levels. A high rate associates with
the more benign adipose hyperplasia.
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